Nalaganje...
Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner
Stroke is associated with neuroinflammation, neuronal loss and blood-brain barrier (BBB) breakdown. Thus far, recombinant tissue-type plasminogen activator (rtPA), the only approved treatment for acute ischemic stroke, increases the risk of intracerebral hemorrhage and is poorly efficient in disaggr...
Shranjeno v:
| izdano v: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals LLC
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5094944/ https://ncbi.nlm.nih.gov/pubmed/27248662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9652 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|